{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T08:38:02Z","timestamp":1787647082479,"version":"build-2736575974"},"reference-count":51,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012151","name":"Sanming Project of Medicine in Shenzen Municipality","doi-asserted-by":"publisher","award":["SZZYSM202211006"],"award-info":[{"award-number":["SZZYSM202211006"]}],"id":[{"id":"10.13039\/501100012151","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajogmfm.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics &amp; Gynecology MFM"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.ajogmf.2024.101572","type":"journal-article","created":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T04:14:13Z","timestamp":1732594453000},"page":"101572","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Comparative effectiveness of low molecular weight heparin on live birth for recurrent spontaneous abortion: systematic review and network meta-analysis"],"prefix":"10.1016","volume":"7","author":[{"given":"Wenrui","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxuan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingzi","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyan","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1358-5477","authenticated-orcid":false,"given":"XueLian","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajogmf.2024.101572_bib0001","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.fertnstert.2023.08.954","article-title":"The prevalence of sporadic and recurrent pregnancy loss","volume":"120","author":"Genovese","year":"2023","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajogmf.2024.101572_bib0002","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/s41572-020-00228-z","article-title":"Recurrent pregnancy loss","volume":"6","author":"Dimitriadis","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.ajogmf.2024.101572_bib0003","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/nrendo.2016.116","article-title":"Fertile ground: human endometrial programming and lessons in health and disease","volume":"12","author":"Evans","year":"2016","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.ajogmf.2024.101572_bib0004","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.fertnstert.2019.11.025","article-title":"Definitions of infertility and recurrent pregnancy loss: a committee opinion","volume":"113","year":"2020","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajogmf.2024.101572_bib0005","article-title":"ESHRE guideline: recurrent pregnancy loss: an update in 2022","author":"Bender Atik","year":"2023","journal-title":"Hum Reprod Open"},{"issue":"5","key":"10.1016\/j.ajogmf.2024.101572_bib0006","first-page":"CD012852","article-title":"Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss","volume":"5","author":"Hamuly\u00e1k","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajogmf.2024.101572_bib0007","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1546-0096-12-47","article-title":"Bone status of children born from mothers with autoimmune diseases treated during pregnancy with prednisone and\/or low molecular weight heparin","volume":"12","author":"Pagnini","year":"2014","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.ajogmf.2024.101572_bib0008","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.thromres.2015.11.026","article-title":"Microvesicles of pregnant women receiving low molecular weight heparin improve trophoblast function","volume":"137","author":"Shomer","year":"2016","journal-title":"Thromb Res"},{"key":"10.1016\/j.ajogmf.2024.101572_bib0009","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/aji.12348","article-title":"Low molecular weight heparin modulates maternal immune response in pregnant women and mice with thrombophilia","volume":"73","author":"Luley","year":"2015","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.ajogmf.2024.101572_bib0010","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.rbmo.2017.06.018","article-title":"Outcomes of threatened abortions after anticoagulation treatment to prevent recurrent pregnancy loss","volume":"35","author":"Rottenstreich","year":"2017","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.ajogmf.2024.101572_bib0011","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1111\/aogs.13147","article-title":"Thromboembolism and in vitro fertilization - a systematic review","volume":"96","author":"Sennstr\u00f6m","year":"2017","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"Suppl 1","key":"10.1016\/j.ajogmf.2024.101572_bib0012","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1016\/S0049-3848(17)30071-3","article-title":"LMWH in IVF - Biomarkers and benefits","volume":"151","author":"Fishel","year":"2017","journal-title":"Thromb Res"},{"key":"10.1016\/j.ajogmf.2024.101572_bib0013","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/978-3-642-23056-1_7","article-title":"Low-molecular-weight heparins: differential characterization\/physical characterization","author":"Guerrini","year":"2012","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.ajogmf.2024.101572_bib0014","doi-asserted-by":"crossref","first-page":"14168","DOI":"10.1038\/s41598-024-62949-5","article-title":"Low-molecular-weight heparin in the prevention of unexplained recurrent miscarriage: a systematic review and meta-analysis","volume":"14","author":"Scarrone","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajogmf.2024.101572_bib0015","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ejogrb.2021.10.036","article-title":"Low molecular weight heparin or LMWH plus aspirin in the treatment of unexplained recurrent miscarriage with negative antiphospholipid antibodies: a meta-analysis of randomized controlled trial","volume":"268","author":"Yan","year":"2022","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajogmf.2024.101572_bib0016","doi-asserted-by":"crossref","first-page":"7601","DOI":"10.1080\/14767058.2021.1957819","article-title":"Evaluation of the effect of low molecular weight heparin in unexplained recurrent pregnancy loss: a meta-analysis of randomized controlled trials","volume":"35","author":"Wang","year":"2022","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajogmf.2024.101572_bib0017","article-title":"Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss","volume":"5","author":"Hamuly\u00e1k","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"45","key":"10.1016\/j.ajogmf.2024.101572_bib0018","doi-asserted-by":"crossref","first-page":"e1732","DOI":"10.1097\/MD.0000000000001732","article-title":"Antithrombotic treatment for recurrent miscarriage: Bayesian network meta-analysis and systematic review","volume":"94","author":"Zhang","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ajogmf.2024.101572_bib0019","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.ajogmf.2024.101572_bib0020","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations","volume":"162","author":"Hutton","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ajogmf.2024.101572_bib0021","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.ajogmf.2024.101572_bib0022","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003082","article-title":"CINeMA: An approach for assessing confidence in the results of a network meta-analysis","volume":"17","author":"Nikolakopoulou","year":"2020","journal-title":"PLoS Med"},{"key":"10.1016\/j.ajogmf.2024.101572_bib0023","doi-asserted-by":"crossref","first-page":"e1080","DOI":"10.1002\/cl2.1080","article-title":"CINeMA: Software for semiautomated assessment of the confidence in the results of network meta-analysis","volume":"16","author":"Papakonstantinou","year":"2020","journal-title":"Campbell Syst Rev"},{"key":"10.1016\/j.ajogmf.2024.101572_bib0024","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-010919","article-title":"Comparative efficacy and acceptability of first-generation and second-generation antidepressants in the acute treatment of major depression: protocol for a network meta-analysis","volume":"6","author":"Furukawa","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.ajogmf.2024.101572_bib0025","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1093\/ije\/dys041","article-title":"Predicting the extent of heterogeneity in meta-analysis, using empirical data from the Cochrane Database of Systematic Reviews","volume":"41","author":"Turner","year":"2012","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.ajogmf.2024.101572_bib0026","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2021-066084","article-title":"Drug treatment for panic disorder with or without agoraphobia: systematic review and network meta-analysis of randomised controlled trials","volume":"376","author":"Chawla","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/j.ajogmf.2024.101572_bib0027","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1093\/eurheartj\/ehu424","article-title":"Systematic reviews and meta-analyses of randomized trials: principles and pitfalls","volume":"35","author":"da Costa","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ajogmf.2024.101572_bib0028","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jclinepi.2010.03.016","article-title":"Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial","volume":"64","author":"Salanti","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.ajogmf.2024.101572_bib0029","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00404-011-2055-y","article-title":"Bemiparin versus low dose aspirin for management of recurrent early pregnancy losses due to antiphospholipd antibody syndrome","volume":"285","author":"Alalaf","year":"2012","journal-title":"Arch Gynecol Obstet"},{"issue":"6","key":"10.1016\/j.ajogmf.2024.101572_bib0030","doi-asserted-by":"crossref","DOI":"10.1111\/aji.12770","article-title":"Use of D-dimer measurement to guide anticoagulant treatment in recurrent pregnancy loss associated with antiphospholipid syndrome","volume":"78","author":"Bao","year":"2017","journal-title":"Am J Reprod Immunol"},{"issue":"3","key":"10.1016\/j.ajogmf.2024.101572_bib0031","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1080\/01443610802042688","article-title":"Low-molecular weight heparin in patients with recurrent early miscarriages of unknown aetiology","volume":"28","author":"Badawy","year":"2008","journal-title":"J Obstet Gynaecol"},{"key":"10.1016\/j.ajogmf.2024.101572_bib0032","doi-asserted-by":"crossref","first-page":"12314","DOI":"10.1038\/s41598-019-48799-6","article-title":"Low-molecular-weight-heparin increases Th1- and Th17-associated chemokine levels during pregnancy in women with unexplained recurrent pregnancy loss: a randomised controlled trial","volume":"9","author":"Rasmark Roepke","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajogmf.2024.101572_bib0033","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1016\/j.fertnstert.2010.12.033","article-title":"The role of low-molecular-weight heparin in recurrent implantation failure: a prospective, quasi-randomized, controlled study","volume":"95","author":"Berker","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajogmf.2024.101572_bib0034","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.fertnstert.2005.12.068","article-title":"A randomized study of thromboprophylaxis in women with unexplained consecutive recurrent miscarriages","volume":"86","author":"Dolitzky","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajogmf.2024.101572_bib0035","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1756-0500-7-23","article-title":"Low dose aspirin and low-molecular-weight heparin in the treatment of pregnant Libyan women with recurrent miscarriage","volume":"7","author":"Elmahashi","year":"2014","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.ajogmf.2024.101572_bib0036","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00404-007-0527-x","article-title":"Treatment options and pregnancy outcome in women with idiopathic recurrent miscarriage: a randomized placebo-controlled study","volume":"278","author":"Fawzy","year":"2008","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ajogmf.2024.101572_bib0037","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ijgo.2010.09.010","article-title":"Enoxaparin versus unfractionated heparin in the management of recurrent abortion secondary to antiphospholipid syndrome","volume":"112","author":"Fouda","year":"2011","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ajogmf.2024.101572_bib0038","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.3109\/14767058.2011.600366","article-title":"Efficacy of three different antithrombotic regimens on pregnancy outcome in pregnant women affected by recurrent pregnancy loss","volume":"25","author":"Giancotti","year":"2012","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajogmf.2024.101572_bib0039","first-page":"1760","article-title":"Immunological effects of anti-coagulant unfractionated heparin in pregnant Chinese women with cryptic recurrent miscarriages","volume":"19","author":"Hong","year":"2020","journal-title":"Arch Med Sci"},{"key":"10.1016\/j.ajogmf.2024.101572_bib0040","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ijgo.2015.09.004","article-title":"Randomized controlled study of pre-conception thromboprophylaxis among patients with recurrent spontaneous abortion related to antiphospholipid syndrome","volume":"132","author":"Ismail","year":"2016","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ajogmf.2024.101572_bib0041","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1056\/NEJMoa1000641","article-title":"Aspirin plus heparin or aspirin alone in women with recurrent miscarriage","volume":"362","author":"Kaandorp","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajogmf.2024.101572_bib0042","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1080\/14767058.2019.1671348","article-title":"Aspirin, low molecular weight heparin, or both in preventing pregnancy complications in women with recurrent pregnancy loss and factor V Leiden mutation","volume":"33","author":"Karada\u011f","year":"2020","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajogmf.2024.101572_bib0043","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3899\/jrheum.080763","article-title":"Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial","volume":"36","author":"Laskin","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ajogmf.2024.101572_bib0044","doi-asserted-by":"crossref","first-page":"78","DOI":"10.4103\/jrms.jrms_81_21","article-title":"The effect of low-molecular-weight heparin on live birth rate of patients with unexplained early recurrent pregnancy loss: a two-arm randomized clinical trial","volume":"27","author":"Mohammad-Akbari","year":"2022","journal-title":"J Res Med Sci"},{"key":"10.1016\/j.ajogmf.2024.101572_bib0045","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1182\/blood-2014-11-610857","article-title":"Enoxaparin for prevention of unexplained recurrent miscarriage: a multicenter randomized double-blind placebo-controlled trial","volume":"125","author":"Pasquier","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.ajogmf.2024.101572_bib0046","doi-asserted-by":"crossref","first-page":"10600","DOI":"10.1038\/s41598-020-67807-8","article-title":"Author correction: low-molecular-weight-heparin increases Th1- and Th17-associated chemokine levels during pregnancy in women with unexplained recurrent pregnancy loss: a randomised controlled trial","volume":"10","author":"Roepke","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajogmf.2024.101572_bib0047","doi-asserted-by":"crossref","first-page":"601","DOI":"10.7326\/M14-2062","article-title":"Low-molecular-weight heparin for women with unexplained recurrent pregnancy loss: a multicenter trial with a minimization randomization scheme","volume":"162","author":"Schleussner","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ajogmf.2024.101572_bib0048","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1177\/1076029616665167","article-title":"Low-molecular-weight heparin for the treatment of unexplained recurrent miscarriage with negative antiphospholipid antibodies: a randomized controlled trial","volume":"23","author":"Shaaban","year":"2017","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.ajogmf.2024.101572_bib0049","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1160\/TH10-05-0334","article-title":"Thromboprophylaxis for recurrent miscarriage in women with or without thrombophilia. HABENOX: a randomised multicentre trial","volume":"105","author":"Visser","year":"2011","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ajogmf.2024.101572_bib0050","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S1701-2163(16)30644-2","article-title":"Treatment of antiphospholipid antibody syndrome (APS) in pregnancy: a randomized pilot trial comparing low molecular weight heparin to unfractionated heparin","volume":"26","author":"Stephenson","year":"2004","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.ajogmf.2024.101572_bib0051","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0140-6736(06)69204-0","article-title":"Recurrent miscarriage","volume":"368","author":"Rai","year":"2006","journal-title":"Lancet"}],"container-title":["American Journal of Obstetrics &amp; Gynecology MFM"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589933324002982?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589933324002982?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T04:20:10Z","timestamp":1778905210000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589933324002982"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S2589933324002982"],"URL":"https:\/\/doi.org\/10.1016\/j.ajogmf.2024.101572","relation":{},"ISSN":["2589-9333"],"issn-type":[{"value":"2589-9333","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative effectiveness of low molecular weight heparin on live birth for recurrent spontaneous abortion: systematic review and network meta-analysis","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics & Gynecology MFM","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajogmf.2024.101572","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101572"}}